Novel Fubinaca/Rimonabant hybrids as endocannabinoid system modulators

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors

(2017) Adriano Mollica et al.   JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice

(2016) Jenny L. Wiley et al.   NEUROPHARMACOLOGY

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

(2015) Samuel D. Banister et al.   ACS Chemical Neuroscience

Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies

(2015) Adriano Mollica et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry

(2015) Marisol S. Castaneto et al.   Forensic Toxicology

A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA

(2015) Michael D. Schwartz et al.   JOURNAL OF EMERGENCY MEDICINE

Synthetic Cannabinoid–Related Illnesses and Deaths

(2015) Jordan Trecki et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of acute detoxification of the herbal blend ‘Spice Gold’ on dopamine D2/3 receptor availability: A [18F]fallypride PET study

(2013) Axel Rominger et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products

(2013) Nahoko Uchiyama et al.   Forensic Toxicology

Emergence and properties of spice and bath salts: A medicinal chemistry perspective

(2013) Anita H. Lewin et al.   LIFE SCIENCES

New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products

(2012) Nahoko Uchiyama et al.   Forensic Toxicology

Synthesis of (S)-5,6-dibromo-tryptophan derivatives as building blocks for peptide chemistry

(2011) Adriano Mollica et al.   TETRAHEDRON LETTERS